Cite
MLA Citation
Sonia Brun et al.. “GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions.” Autophagy, vol. 18, no. 3, 2022, pp. 678–694. http://access.bl.uk/ark:/81055/vdc_100153750213.0x000018